Ironwood Hits Phase III Endpoint In SBS-IF, But Shareholders Show Wariness

 
• By Joseph Haas
  
Ironwood's Phase III trial will lead to an FDA filing in SBS-IF
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D